| Product Code: ETC6748916 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Obesity Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Obesity Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Obesity Drugs Market - Industry Life Cycle |
3.4 China Obesity Drugs Market - Porter's Five Forces |
3.5 China Obesity Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Obesity Drugs Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.7 China Obesity Drugs Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.8 China Obesity Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Obesity Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity in China |
4.2.2 Rising awareness about the health risks associated with obesity |
4.2.3 Growing disposable income leading to higher spending on healthcare products |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for obesity drugs in China |
4.3.2 Cultural perceptions and stigma associated with seeking treatment for obesity |
5 China Obesity Drugs Market Trends |
6 China Obesity Drugs Market, By Types |
6.1 China Obesity Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Obesity Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Obesity Drugs Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 China Obesity Drugs Market Revenues & Volume, By OTC Drugs, 2021- 2031F |
6.2 China Obesity Drugs Market, By Age |
6.2.1 Overview and Analysis |
6.2.2 China Obesity Drugs Market Revenues & Volume, By Children, 2021- 2031F |
6.2.3 China Obesity Drugs Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.4 China Obesity Drugs Market Revenues & Volume, By Old, 2021- 2031F |
6.3 China Obesity Drugs Market, By Gender |
6.3.1 Overview and Analysis |
6.3.2 China Obesity Drugs Market Revenues & Volume, By Male, 2021- 2031F |
6.3.3 China Obesity Drugs Market Revenues & Volume, By Female, 2021- 2031F |
6.4 China Obesity Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Obesity Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 China Obesity Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 China Obesity Drugs Market Revenues & Volume, By Online, 2021- 2031F |
7 China Obesity Drugs Market Import-Export Trade Statistics |
7.1 China Obesity Drugs Market Export to Major Countries |
7.2 China Obesity Drugs Market Imports from Major Countries |
8 China Obesity Drugs Market Key Performance Indicators |
8.1 Percentage increase in the number of obese individuals seeking medical treatment |
8.2 Adoption rate of new obesity drugs in the market |
8.3 Growth in the number of healthcare facilities offering obesity treatment services |
9 China Obesity Drugs Market - Opportunity Assessment |
9.1 China Obesity Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Obesity Drugs Market Opportunity Assessment, By Age, 2021 & 2031F |
9.3 China Obesity Drugs Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.4 China Obesity Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Obesity Drugs Market - Competitive Landscape |
10.1 China Obesity Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Obesity Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here